# Combination Gerotherapeutic Interventions for Healthspan Improvement

> **NCT07475546** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **AgelessRx** · enrollment: 30 (estimated)

## Conditions studied

- Healthspan Improvement
- Aging
- Longevity

## Interventions

- **DRUG:** Rapamycin
- **DRUG:** Naltrexone
- **DRUG:** Metformin
- **DRUG:** NAD+
- **DRUG:** GSH
- **DIETARY_SUPPLEMENT:** Infinite Supplement
- **DRUG:** Placebo/control
- **DIETARY_SUPPLEMENT:** B12
- **BEHAVIORAL:** Intervention: Guided Meditation Program
- **BEHAVIORAL:** Control: Podcast Listening Activity
- **BEHAVIORAL:** Control: Standard Exercise Regimen
- **BEHAVIORAL:** Intervention: Structured Exercise Program

## Key facts

- **NCT ID:** NCT07475546
- **Lead sponsor:** AgelessRx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-23
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07475546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07475546, "Combination Gerotherapeutic Interventions for Healthspan Improvement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07475546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*